Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00681590 · ClinicalTrials.gov registry record · Phase 3

Safety of Vitamin D Supplementation in Older Persons

A Phase 3 study of Vitamin D Deficiency, sponsored by University of Miami.

Completed
Registry status
Phase 3
Development phase
105
Enrollment target
1
Study location

NCT00681590 is a Phase 3 study of Vitamin D Deficiency that has completed, run by University of Miami. The registered enrollment target is 105 participants, below the 273-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00681590, a Phase 3 study of Vitamin D Deficiency, has completed, sponsored by University of Miami.

COMPLETED
Registry status
Phase 3
Development phase
105 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the safety over 6 months of two different doses of vitamin D (cholecalciferol) in men and women age 65 and older. It will also evaluate if supplementation with vitamin D improves physical performance.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT cholecalciferol (vitamin D)

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2008-04
Est. Completion 2009-04
Phase Phase 3

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT00681590

The ClinicalTrials.gov registry entry for NCT00681590 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 273-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (62% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vitamin D Deficiency appearing as the primary indexed condition, and to 1 intervention - of which cholecalciferol (vitamin D) is the first listed.

NCT00681590 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00681590 about?

NCT00681590 is a clinical study titled "Safety of Vitamin D Supplementation in Older Persons". This study will evaluate the safety over 6 months of two different doses of vitamin D (cholecalciferol) in men and women age 65 and older. It will also evaluate if supplementation with vitamin D improves physical performance.

What is the current status of trial NCT00681590?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 105 participants. The study started on 2008-04. Estimated completion is 2009-04.

What conditions does trial NCT00681590 study?

This clinical trial studies the following conditions: Vitamin D Deficiency.

What interventions are being tested in trial NCT00681590?

The interventions under investigation include: cholecalciferol (vitamin D) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00681590?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00681590 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vitamin D Deficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.